Gasdermin D-Mediated Pyroptosis in Diabetic Cardiomyopathy: Molecular Mechanisms and Pharmacological Implications

Area of Science:

• Cardiovascular Biology
• Molecular Cell Biology
• Endocrinology

Background:

• Diabetic cardiomyopathy (DCM) is a complication of diabetes mellitus (DM), leading to heart failure (HF).
• Cardiomyocyte death is a key feature of DCM.
• Pyroptosis, a form of programmed cell death mediated by Gasdermin D (GSDMD), is implicated in DCM development, particularly during hyperglycemia.

Purpose of the Study:

• To elucidate the role of Gasdermin D (GSDMD) in diabetic cardiomyopathy (DCM).
• To review the structural and mechanistic aspects of GSDMD-mediated pyroptosis relevant to DCM.
• To explore the therapeutic potential of targeting GSDMD in DCM.

Main Methods:

• Literature review focusing on GSDMD structure, function, and pyroptosis mechanisms.
• Analysis of recent studies linking hyperglycemia, pyroptosis, and DCM.
• Synthesis of information on GSDMD activation pathways and molecular mechanisms.

Main Results:

• GSDMD is a critical mediator of pyroptosis, a cell death pathway activated by hyperglycemia in DCM.
• Understanding GSDMD's structure and pore-formation mechanism is key to its role in DCM.
• Emerging evidence suggests GSDMD is a significant factor in DCM pathogenesis.

Conclusions:

• GSDMD-mediated pyroptosis is a crucial cellular process in the development of diabetic cardiomyopathy.
• Targeting GSDMD presents a promising therapeutic strategy for managing DCM.
• Further research into GSDMD mechanisms could unlock novel treatments for heart conditions associated with diabetes.